Document
IPR2023-00724, No. 1301 Exhibit - Exhibit 1301 Jusko Decl (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1301 Exhibit - Exhibit 1301 Jusko Decl (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1105 Exhibit - Exhibit 1105 Victoza Orange Book (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1105 Exhibit - Exhibit 1105 Victoza Orange Book (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2554 Exhibit - EX2554 Transcript of July 16, 2024 Deposition of Steven Coca, MD (P.T.A.B. Aug. 5, 2024)
Cite Document
IPR2023-00724, No. 2554 Exhibit - EX2554 Transcript of July 16, 2024 Deposition of Steven Coca, MD (P.T.A.B. Aug. 5, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2547 Exhibit - EX2547 Email Notice of Electronic Filing Corresponding to In re Ozempic Semaglutide Patent Litigation, No 122 cv 03038 CFC Dkt 314 (P.T.A.B. Jul. 31, 2024...
Cite Document
IPR2023-00724, No. 2547 Exhibit - EX2547 Email Notice of Electronic Filing Corresponding to In re Ozempic Semaglutide Patent Litigation, No 122 cv 03038 CFC Dkt 314 (P.T.A.B. Jul. 31, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1132 Exhibit - Exhibit 1132 Amori (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1132 Exhibit - Exhibit 1132 Amori (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2500 Exhibit - EX2500 Novo Nordisk, Financial report for the period 1 January 2019 to 30 September 2019 Nov 1, 2019 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2500 Exhibit - EX2500 Novo Nordisk, Financial report for the period 1 January 2019 to 30 September 2019 Nov 1, 2019 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2418 Exhibit - EX2418 US Food Drug Administration, DrugsFDA, Bydureon® (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2418 Exhibit - EX2418 US Food Drug Administration, DrugsFDA, Bydureon® (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2517 Exhibit - EX2517 Merck Provides Update on Combination Medicine JUVISYNC™ sitagliptin and simvastatin Tablets, httpswwwmerckcomnewsmerck provides update on...
Cite Document
IPR2023-00724, No. 2517 Exhibit - EX2517 Merck Provides Update on Combination Medicine JUVISYNC™ sitagliptin and simvastatin Tablets, httpswwwmerckcomnewsmerck provides update on combination medicin
+ More Snippets
Document
IPR2023-00724, No. 2370 Exhibit - EX2370 White, Jr, JR, A Brief History of the Development of Diabetes Medications, Diabetes Spectr 201427282 86 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2370 Exhibit - EX2370 White, Jr, JR, A Brief History of the Development of Diabetes Medications, Diabetes Spectr 201427282 86 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 2513 Exhibit - EX2513 Novo Nordisk, Financial report for the period 1 January 2022 to 31 December 2022 Feb 1, 2023 (P.T.A.B. Jan. 17, 2024)
Cite Document
IPR2023-00724, No. 2513 Exhibit - EX2513 Novo Nordisk, Financial report for the period 1 January 2022 to 31 December 2022 Feb 1, 2023 (P.T.A.B. Jan. 17, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1080 Exhibit - NCT490 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1080 Exhibit - NCT490 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1051 Exhibit - Landersdorfer 2008 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1051 Exhibit - Landersdorfer 2008 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1022 Exhibit - Drab 2010 (P.T.A.B. Mar. 16, 2023)
Cite Document
IPR2023-00724, No. 1022 Exhibit - Drab 2010 (P.T.A.B. Mar. 16, 2023)
+ More Snippets
Document
IPR2023-00724, No. 1145 Exhibit - Exhibit 1145 Pyram (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1145 Exhibit - Exhibit 1145 Pyram (P.T.A.B. May. 22, 2024)
+ More Snippets
Document
IPR2023-00724, No. 1147 Exhibit - Exhibit 1147 Vollenweider (P.T.A.B. May. 22, 2024)
Cite Document
IPR2023-00724, No. 1147 Exhibit - Exhibit 1147 Vollenweider (P.T.A.B. May. 22, 2024)
+ More Snippets